Quantum Biopharma (QNTM) Invested Capital (2019 - 2026)

Quantum Biopharma has disclosed Invested Capital across 8 years of filings, most recently posting $595226.0 for Q1 2026.

• Invested Capital for Q1 2026 came in at $595226.0, down 89.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $595226.0 (down 89.62% YoY), and the FY2025 annual result was $8.2 million, down 32.02% from the prior year.
• Invested Capital came in at $595226.0 for Q1 2026 at Quantum Biopharma, down from $8.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $30.5 million in Q4 2022 to a low of $595226.0 in Q1 2026.
• The 5-year median for Invested Capital is $9.8 million (2024), against an average of $11.2 million.
• Across the five-year window, Invested Capital gained 9.8% in 2024 and tumbled 89.62% in 2026, its largest moves.
• Quantum Biopharma's Invested Capital stood at $30.5 million in 2022, then tumbled by 51.42% to $14.8 million in 2023, then retreated by 18.44% to $12.1 million in 2024, then sank by 32.02% to $8.2 million in 2025, then slumped by 92.76% to $595226.0 in 2026.
• The last three Invested Capital figures came in at $595226.0 (Q1 2026), $8.2 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.